| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.02. | IRLAB Therapeutics - EMA alignment on mesdopetam Phase III plans | 353 | Edison Investment Research | IRLAB has bolstered the value of its lead programme, mesdopetam in levodopa-induced dyskinesias (PD-LIDs), following confirmation that the European Medicines Agency (EMA) is aligned with the company... ► Artikel lesen | |
| 20.02. | Metlen (ASE: MYTIL) FY24 Results | 264 | Edison Investment Research | Metlen's FY24 results released on 20 February were broadly in line with consensus (EBITDA €1,080bn, 0.9% above consensus of €1,070bn and 2.4% above Edison of €1055bn, EPS €4.46, 2.2% below consensus... ► Artikel lesen | |
| 20.02. | Mendus - Vididencel on track in AML going into 2025 | 274 | Edison Investment Research | Mendus has reported its FY24 results, reflecting an active period. Lead programme, vididencel in acute myeloid leukaemia (AML), had encouraging data from the ADVANCE II trial in December, laying the... ► Artikel lesen | |
| 20.02. | Recce Pharmaceuticals - Positive R327G Phase II ABSSSI study results | 358 | Edison Investment Research | Recce has reported positive results from its open-label Phase II study assessing RECCE® 327 topical gel (R327G) in patients with acute bacterial skin and skin structure infections (ABSSSI), including... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 726 |
| EVOTEC | 398 |
| NOVO NORDISK | 377 |
| TESLA | 344 |
| RHEINMETALL | 308 |
| BYD | 284 |
| RENK GROUP | 198 |
| DEUTZ | 196 |
| BAYER | 166 |
| BASF | 159 |
| TUI | 158 |
| STEYR MOTORS | 153 |
| APPLE | 151 |
| VOLKSWAGEN | 146 |
| NETFLIX | 145 |
| PLUG POWER | 141 |
| AMAZON | 137 |
| ALMONTY | 133 |
| UNITEDHEALTH | 132 |
| NEL | 130 |
| COMMERZBANK | 129 |
| DEUTSCHE BANK | 128 |
| XIAOMI | 128 |
| E.ON | 126 |
| RWE | 123 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
